Resumen acción BLISSGVS
Bliss GVS Pharma Limited desarrolla, fabrica y comercializa formulaciones farmacéuticas en la India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Competidores de Bliss GVS Pharma Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹110.30 |
| 52 Week High | ₹149.60 |
| 52 Week Low | ₹70.85 |
| Beta | 0.99 |
| 1 Month Change | 0.14% |
| 3 Month Change | -15.67% |
| 1 Year Change | 49.26% |
| 3 Year Change | 19.44% |
| 5 Year Change | -34.85% |
| Change since IPO | 171.34% |
Noticias y actualizaciones recientes
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Recent updates
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?
Aug 17The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More
Aug 04Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)
Aug 04Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Jul 06Rentabilidad de los accionistas
| BLISSGVS | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | -5.2% | -2.1% | -0.03% |
| 1Y | 49.3% | 57.5% | 46.9% |
Rentabilidad vs. Industria: BLISSGVS obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 62.5%.
Rentabilidad vs. Mercado: BLISSGVS superó al mercado Indian, que obtuvo un rendimiento del 42% el año pasado.
Volatilidad de los precios
| BLISSGVS volatility | |
|---|---|
| BLISSGVS Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: BLISSGVS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de BLISSGVS (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1984 | 763 | Gagan Sharma | www.blissgvs.com |
Bliss GVS Pharma Limited desarrolla, fabrica y comercializa formulaciones farmacéuticas en la India. Ofrece productos farmacéuticos como cápsulas, cremas/geles/ungüentos, polvo seco para inyecciones y suspensiones orales, comprimidos efervescentes, colirios, inyecciones, preparados líquidos, lociones, pastillas, soluciones nasales, sólidos orales, parenterales, pesarios, sobres, cápsulas de gelatina blanda, supositorios, suspensiones, jarabes, comprimidos, preparados tópicos y parches transdérmicos. La empresa suministra otros productos sanitarios, como bálsamos, cremas, lociones, pastillas, inhaladores nasales, productos de venta libre, vaselinas, polvos, roll-ons, champús, jabones, soluciones, sprays, jarabes y lavados vaginales.
Resumen de fundamentos de Bliss GVS Pharma Limited
| Estadísticas fundamentales de BLISSGVS | |
|---|---|
| Capitalización bursátil | ₹11.53b |
| Beneficios(TTM) | ₹879.46m |
| Ingresos (TTM) | ₹7.57b |
13.1x
Ratio precio-beneficio (PE)1.5x
Ratio precio-ventas (PS)¿Está BLISSGVS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BLISSGVS | |
|---|---|
| Ingresos | ₹7.57b |
| Coste de los ingresos | ₹4.08b |
| Beneficio bruto | ₹3.49b |
| Otros gastos | ₹2.61b |
| Beneficios | ₹879.46m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 8.40 |
| Margen bruto | 46.11% |
| Margen de beneficio neto | 11.62% |
| Ratio deuda/patrimonio | 10.3% |
¿Cómo se ha desempeñado BLISSGVS a largo plazo?
Ver rendimiento histórico y comparativa